Home

Bioworkshops sell "Dostarlimab"

Basic Information

375
15
4
4.6(50)

Trade Type

Sell

Product Name

Dostarlimab

Manufacturer(s)

Specifications

  • Expression System: Mammalian cell line expression system with DMF filing, optimized for high titer and broad media adaptability
  • Purity: High degree of analytical comparability to the reference product
  • Regulatory Status: Approved in the European Union, Iceland, Liechtenstein and Norway (21 April 2021); DMF-filed cell line for global regulatory readiness
  • Application: PD-1 inhibitor monoclonal antibody targeting neoplasms, urogenital and nervous-system diseases; representative indications include microsatellite-instability-high and mismatch-repair-deficient endometrial carcinoma

Documents

GMP
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product